Trials / Completed
CompletedNCT01798264
Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes
A Phase Ib, Randomized, Open-Label, Multi-Center, 4-Week Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ITCA 650 in Subjects With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Intarcia Therapeutics · Industry
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
evaluate the safety and tolerability of ITCA 650 in subjects with type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ITCA 650 (exenatide in DUROS) |
Timeline
- Start date
- 2009-02-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2013-02-25
- Last updated
- 2013-05-17
- Results posted
- 2013-05-17
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01798264. Inclusion in this directory is not an endorsement.